Jefferies Financial Group Inc. Purchases 26,294 Shares of Cabot Corporation $CBT

Posted by on May 27th, 2026

Jefferies Financial Group Inc. raised its position in shares of Cabot Corporation (NYSE:CBT – Free Report) by 255.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,570 shares of the specialty chemicals company’s stock after purchasing an additional 26,294 shares during the period. Jefferies Financial Group Inc.’s holdings in Cabot were worth $2,424,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Ashton Thomas Private Wealth LLC grew its holdings in Cabot by 343.9% during the third quarter. Ashton Thomas Private Wealth LLC now owns 65,561 shares of the specialty chemicals company’s stock valued at $4,986,000 after purchasing an additional 50,792 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Cabot by 5.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,556,762 shares of the specialty chemicals company’s stock worth $118,392,000 after acquiring an additional 73,734 shares during the period. Elo Mutual Pension Insurance Co bought a new position in shares of Cabot in the third quarter worth $1,040,000. UBS Group AG boosted its holdings in shares of Cabot by 3.5% in the fourth quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock worth $40,708,000 after acquiring an additional 20,668 shares during the period. Finally, Royce & Associates LP boosted its holdings in shares of Cabot by 37.5% in the third quarter. Royce & Associates LP now owns 106,980 shares of the specialty chemicals company’s stock worth $8,136,000 after acquiring an additional 29,202 shares during the period. 93.18% of the stock is owned by institutional investors.

Cabot Trading Up 1.7%

Shares of CBT stock opened at $84.80 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $86.43. The company has a market capitalization of $4.38 billion, a PE ratio of 16.03, a price-to-earnings-growth ratio of 10.91 and a beta of 0.78. The business’s fifty day moving average is $76.48 and its 200 day moving average is $71.70.

Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. During the same quarter last year, the business posted $1.90 earnings per share. The firm’s revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities research analysts anticipate that Cabot Corporation will post 6.32 EPS for the current fiscal year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be given a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. Cabot’s dividend payout ratio (DPR) is 34.03%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on CBT shares. JPMorgan Chase & Co. raised their price target on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a report on Wednesday, May 13th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price target on shares of Cabot in a report on Wednesday, February 4th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. UBS Group raised their price target on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Finally, Mizuho raised their price target on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $80.25.

View Our Latest Report on CBT

Cabot Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Articles

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.